Overcoming Drug Resistance with EAI-432, an Allosteric EGFR Inhibitor for Non-Small Cell Lung Cancer
Researchers at Dana-Farber Cancer Institute have developed a promising new drug candidate, EAI-432, to treat…
sciencecityDecember 4, 2023
Scientists at Harvard Medical School have shown for the first time that a common skin…
sciencecityDecember 1, 2023
A team of scientists at the Whitehead Institute for Biomedical Research and MIT has spatially mapped…
sciencecityNovember 30, 2023
A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women’s Hospital (BWH), and…
sciencecityNovember 30, 2023
PIK3CA mutations occur in ~8% of cancers, including ~40% of HR-positive breast cancers, where the…
sciencecityNovember 24, 2023
DNA methyltransferases (DNMTs) are increased in neuroendocrine prostate cancer (NEPC), an aggressive cancer associated with…
sciencecityNovember 22, 2023
The immune system is a crucial part of our survival, regularly fending off wide-ranging attacks…
sciencecityNovember 21, 2023
Marcus Ruscetti, PhD, assistant professor of molecular, cell & cancer biology, received a Research Scholar…
sciencecityNovember 20, 2023
Mutations in SNCA, the gene encoding α-synuclein (αSyn), cause familial Parkinson’s disease (PD) and aberrant…
sciencecityNovember 20, 2023
